Publikationen in Zusammenarbeit mit Forschern von Vanderbilt University Medical Center (48)

2024

  1. An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)

    Kidney International, Vol. 105, Núm. 5, pp. 1058-1076

  2. CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility

    Cancer research, Vol. 84, Núm. 4, pp. 616-625

  3. Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation

    Journal of the Society for Cardiovascular Angiography and Interventions, Vol. 3, Núm. 2

  4. Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls

    Cancer, Vol. 130, Núm. 6, pp. 913-926

  5. Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification

    Genome Medicine, Vol. 16, Núm. 1

  6. Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

    Cancer Epidemiology Biomarkers and Prevention, Vol. 33, Núm. 3, pp. 389-399

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions

    Journal of the National Cancer Institute, Vol. 115, Núm. 6, pp. 712-732

  3. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

    Nature Communications, Vol. 14, Núm. 1

  4. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis

    Journal of Thoracic Oncology, Vol. 18, Núm. 8, pp. 1003-1016

2022

  1. A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians

    Journal of Thoracic Oncology, Vol. 17, Núm. 8, pp. 974-990

  2. A first update on mapping the human genetic architecture of COVID-19

    Nature

  3. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

    Nature Genetics, Vol. 54, Núm. 8, pp. 1167-1177

  4. Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer

    European Journal of Medical Research, Vol. 27, Núm. 1

  5. Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk

    Human molecular genetics, Vol. 31, Núm. 16, pp. 2831-2843

  6. I am hiQ—a novel pair of accuracy indices for imputed genotypes

    BMC Bioinformatics, Vol. 23, Núm. 1

  7. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Assessing lung cancer absolute risk trajectory based on a polygenic risk model

    Cancer Research, Vol. 81, Núm. 6, pp. 1607-1615

  2. Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

    International Journal of Cancer, Vol. 148, Núm. 5, pp. 1077-1086

  3. Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma

    Frontiers of Medicine, Vol. 15, Núm. 2, pp. 275-291